European Organisation For Research And Treatment Of Cancer - Eortc

This early-phase study tested the drug TG02 in 71 patients with aggressive brain cancers (anaplastic astrocytoma or glioblastoma). It included older newly diagnosed patients and adults whose cancer had returned. The goal was to find the safest dose of TG02 when combined with eith…

This study followed 830 women who finished treatment for early or locally advanced breast cancer (but not yet metastatic). Researchers used questionnaires to measure quality of life, including physical, emotional, and sexual health. The goal was to understand how survivors feel a…